ONE of Ringaskiddy’s main employers, Novartis, has this morning announced the loss of up to 320 jobs at its Co Cork plant.
It says the losses are as a result of its intention to consolidate its active pharma ingredient (API) manufacturing operations by mid-2022.
It says this will result in the ‘exit’ of one of its production buildings.
Novartis also announced the relocation of a number of jobs by the end of 2021 to ‘centralised operations centers (sic) in Europe and Asia’.
It said the Cork job losses were part of ‘a strategic decision and part of the ongoing evaluation of the Novartis manufacturing network’ around the world. Full story in this week’s Star, out tomorrow.